These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2933878)

  • 21. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis.
    Crippa G; Cagnoni C; Castelli A; Concesi C; Girometta S; Pancotti D; Sverzellati E; Tacchini G; Pierfranceschi MG; Carrara GC
    Clin Ter; 1995 May; 146(5):367-72. PubMed ID: 7796569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients.
    Christensen E; Crowe J; Doniach D; Popper H; Ranek L; Rodés J; Tygstrup N; Williams R
    Gastroenterology; 1980 Feb; 78(2):236-46. PubMed ID: 7350046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Primary biliary cirrhosis: 12-year experience in observation].
    Golovnova EV; Il'chenko LIu; Tsaregorodtseva TM; Serova TI; Gudkova RV; Shepeleva SD; Tkachev VD
    Ter Arkh; 2003; 75(2):26-30. PubMed ID: 12685386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study.
    Hashimoto E; Shimada M; Noguchi S; Taniai M; Tokushige K; Hayashi N; Takasaki K; Fuchinoue S; Ludwig J
    Liver Transpl; 2001 Jul; 7(7):588-95. PubMed ID: 11460225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
    Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early features of primary biliary cirrhosis: an analysis of 85 patients.
    Crowe J; Christensen E; Doniach D; Popper H; Tygstrup N; Williams R
    Am J Gastroenterol; 1985 Jun; 80(6):466-8. PubMed ID: 4003376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What is the onset of primary biliary liver cirrhosis?].
    Linhart P; Börner N; Leiss O
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():94-5. PubMed ID: 7483729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
    Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
    Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
    Twaddell WS; Lefkowitch J; Berk PD
    Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and incidence of primary biliary cirrhosis are increasing in Finland.
    Rautiainen H; Salomaa V; Niemelå S; Karvonen AL; Nurmi H; Isoniemi H; Färkkilä M
    Scand J Gastroenterol; 2007 Nov; 42(11):1347-53. PubMed ID: 17918011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis for prognostic parameters and response to ursodeoxycholic acid].
    Wirth HP; Zala G; Meyenberger C; Ammann R
    Schweiz Med Wochenschr; 1995 Apr; 125(15):750-4. PubMed ID: 7740290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation.
    Balan V; Batts KP; Porayko MK; Krom RA; Ludwig J; Wiesner RH
    Hepatology; 1993 Dec; 18(6):1392-8. PubMed ID: 8244263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
    Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
    Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary biliary cirrhosis (PBC).
    Ahmed N; DeCoux R; Thompson FA; Achord JL
    J Miss State Med Assoc; 1979 Dec; 20(12):271-6. PubMed ID: 513124
    [No Abstract]   [Full Text] [Related]  

  • 40. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group.
    Poupon RE; Bonnand AM; Chrétien Y; Poupon R
    Hepatology; 1999 Jun; 29(6):1668-71. PubMed ID: 10347106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.